TIL
Income statement / Annual
Last year (2024), Instil Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Instil Bio, Inc.'s net income was -$74.14 M.
See Instil Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$138,000.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$4.76 M
|
$5.99 M
|
$2.75 M
|
$0.00
|
$20,000.00
|
| Gross Profit |
$0.00
|
-$4.76 M
|
-$5.99 M
|
-$2.75 M
|
$138,000.00
|
-$20,000.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
1
|
0
|
| Research and Development Expenses |
$10.00 M
|
$42.99 M
|
$141.06 M
|
$107.25 M
|
$19.40 M
|
$4.03 M
|
| General & Administrative Expenses |
$44.21 M
|
$47.55 M
|
$62.24 M
|
$48.31 M
|
$14.38 M
|
$2.56 M
|
| Selling & Marketing Expenses |
$0.00
|
-$4.76 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$44.21 M
|
$42.80 M
|
$62.24 M
|
$48.31 M
|
$14.38 M
|
$2.56 M
|
| Other Expenses |
$19.33 M
|
$0.00
|
-$564,000.00
|
-$1.20 M
|
-$4.66 M
|
-$5,000.00
|
| Operating Expenses |
$73.54 M
|
$85.79 M
|
$203.29 M
|
$155.56 M
|
$33.78 M
|
$6.59 M
|
| Cost And Expenses |
$73.54 M
|
$90.54 M
|
$203.29 M
|
$155.56 M
|
$33.78 M
|
$6.59 M
|
| Interest Income |
$6.99 M
|
$8.87 M
|
$3.66 M
|
$0.00
|
$70,000.00
|
$68,000.00
|
| Interest Expense |
$8.00 M
|
$5.21 M
|
$1.88 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$3.61 M
|
$4.76 M
|
$5.99 M
|
$2.75 M
|
$256,000.00
|
$20,000.00
|
| EBITDA |
-$62.53 M |
-$146.12 M |
-$217.38 M |
-$154.00 M |
-$33.39 M |
-$6.50 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-241.94
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-243.8
|
0
|
| Total Other Income/Expenses Net |
-$594,000.00
|
-$65.55 M
|
$1.21 M
|
-$1.20 M
|
-$3.94 M
|
$63,000.00
|
| Income Before Tax |
-$74.14 M
|
-$156.09 M
|
-$225.25 M
|
-$156.76 M
|
-$37.59 M
|
-$6.52 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-272.37
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$2.07 M
|
$39,000.00
|
$151,000.00
|
-$68,000.00
|
| Net Income |
-$74.14 M
|
-$156.09 M
|
-$223.18 M
|
-$156.79 M
|
-$37.74 M
|
-$6.45 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-273.46
|
0
|
| EPS |
-11.39 |
-24 |
-34.46 |
-24.3 |
-5.89 |
-1.01 |
| EPS Diluted |
-11.39 |
-24 |
-34.46 |
-24.3 |
-5.89 |
-1.01 |
| Weighted Average Shares Out |
$6.51 M
|
$6.50 M
|
$6.48 M
|
$6.45 M
|
$6.41 M
|
$6.41 M
|
| Weighted Average Shares Out Diluted |
$6.51 M
|
$6.50 M
|
$6.48 M
|
$6.45 M
|
$6.41 M
|
$6.41 M
|
| Link |
|
|
|
|
|
|
